Clinical Trials in Russia – Report of the 3rd Quarter 2012
The Ministry of Health and Social Development of the Russian Federation (MoH) approved 210 new clinical trials of all types, including local and bioequivalence studies, during the third quarter of 2012, demonstrating a 59% increase comparing to the same point of the last year. Igor Stefanov of Synergy Research provides an overview of the third quarter analysis of the year 2012 within the Russian Federation.
http://jforcs.com/jcs/wp-content/uploads/2013/02/3-Clinical-Trials-in-Russia-Report-of-the-3rd-Quarter-2012.pdf